Specification Sheet

Pos	No.	Sex	Age	Organ	Pathology diagnosis	Grade	Stage	TNM	Type †
A1	1	F	21	Uterus	Normal endometrium tissue	–	–	–	Normal
A2	2	F	21	Uterus	Normal endometrium tissue	–	–	–	Normal
A3	3	F	18	Uterus	Normal endometrium tissue	–	–	–	Normal
A4	4	F	30	Uterus	Cancer adjacent normal cervix tissue	–	–	–	NAT
A5	5	F	50	Uterus	Cancer adjacent normal cervix tissue	–	–	–	NAT
A6	6	F	31	Uterus	Cancer adjacent normal cervix tissue with focal hyperplasia of squamous epithelium	–	–	–	NAT
A7	7	F	21	Striated muscle	Normal skeletal muscle tissue	–	–	–	Normal
A8	8	M	30	Striated muscle	Normal skeletal muscle tissue	–	–	–	Normal
A9	9	M	35	Striated muscle	Normal skeletal muscle tissue	–	–	–	Normal
B1	10	F	18	Skin	Normal skin tissue	–	–	–	Normal
B2	11	M	37	Skin	Normal skin tissue	–	–	–	Normal
B3	12	M	34	Skin	Normal skin tissue	–	–	–	Normal
B4	13	F	15	Nerve	Normal nervous tissue (sparse)	–	–	–	Normal
B5	14	F	27	Nerve	Normal nervous tissue	–	–	–	Normal
B6	15	M	31	Nerve	Normal nervous tissue	–	–	–	Normal
B7	16	M	48	Lung	Normal mesothelium tissue (lung tissue sparse)	–	–	–	Normal
B8	17	M	22	Lung	Normal mesothelium and lung tissue	–	–	–	Normal
B9	18	M	47	Lung	Normal mesothelium tissue (lung tissue)	–	–	–	Normal
C1	19	F	59	Cerebrum	Glioblastoma	–	–	–	Malignant
C2	20	F	65	Cerebrum	Atypical meningioma	–	–	–	Malignant
C3	21	F	15	Cerebrum	Malignant ependymoma	–	–	–	Malignant
C4	22	M	55	Cerebrum	Malignant oligodendroglioma	–	–	–	Malignant
C5	23	F	49	Ovary	Serous papillary adenocarcinoma	3	II	T3N0M0	Malignant
C6	24	F	54	Ovary	Mucinous papillary adenocarcinoma	2	IIa	T2aN0M0	Malignant
C7	25	M	25	Pancreas	Islet cell carcinoma	–	II	T2N0M0	Malignant
C8	26	M	64	Pancreas	Adenocarcinoma	3	II	T3N0M0	Malignant
C9	27	M	32	Testis	Seminoma	–	–	–	Malignant
D1	28	M	25	Testis	Embryonal carcinoma	–	II	T4N1M0	Malignant
D2	29	F	33	Thyroid	Medullary carcinoma	–	II	T3N0M0	Malignant
D3	30	F	36	Thyroid gland	Papillary carcinoma	–	III	T2aN1M0	Malignant
D4	31	F	28	Breast	Intraductal carcinoma	–	IIb	T3N0M0	Malignant
D5	32	F	43	Breast	Intraductal carcinoma with early infiltrate	–	IIa	T2N0M0	Malignant
D6	33	F	39	Breast	Invasive ductal carcinoma	2	IIb	T2N1M0	Malignant
D7	34	M	27	Spleen	Diffuse large B-cell lymphoma	–	–	–	Malignant
D8	35	M	44	Lung	Small cell undifferentiated carcinoma	–	II	T2N1M0	Malignant
D9	36	M	67	Lung	Squamous cell carcinoma	2	II	T2N1M0	Malignant
E1	37	F	64	Lung	Adenocarcinoma	2	I	T2N0M0	Malignant
E2	38	F	57	Esophagus	Squamous cell carcinoma	2	IIa	T2N0M0	Malignant
E3	39	F	67	Esophagus	Adenocarcinoma	3	III	T4N0M0	Malignant
E4	40	F	73	Stomach	Mucinous adenocarcinoma	3	II	T2N1M0	Malignant
E5	41	M	50	Colon	Adenocarcinoma	2	II	T3N0M0	Malignant
E6	42	F	71	Intestine	Intermediate grade malignant interstitialoma	–	IIb	T2bN0M0	Malignant
E7	43	M	74	Colon	Adenocarcinoma	2	II	T3N0M0	Malignant
E8	44	M	54	Abdominal cavity	Malignant interstitialoma	–	IIb	T2N0M0	Malignant
E9	45	F	50	Rectum	Adenocarcinoma	2	II	T3N1M0	Malignant
F1	46	M	32	Rectum	Interstitialoma	–	IIa	T1bN0M0	Malignant
F2	47	M	61	Liver	Hepatocellular carcinoma	2	II	T2N0M0	Malignant
F3	48	F	17	Liver	Hepatoblastoma	–	–	–	Malignant
F4	49	M	58	Kidney	Clear cell carcinoma	1	II	T2N0M0	Malignant
F5	50	M	76	Prostate	Adenocarcinoma (carcinoma sparse)	–	IV	T3N1M1b	Malignant
F6	51	M	72	Prostate	Adenocarcinoma (Gleason grade:4 Gleason score:4+5)	4	IV	T2N0M1	Malignant
F7	52	F	45	Uterus	Leiomyoma	–	–	–	Benign
F8	53	F	51	Uterus	Endometrial adenocarcinoma	3	Ic	T1cN0M0	Malignant
F9	54	F	39	Uterus	Clear cell carcinoma	–	IIb	T2bN0M0	Malignant
G1	55	F	36	Uterine cervix	Squamous cell carcinoma	2	Ib	T1bN0M0	Malignant
G2	56	F	35	Uterine cervix	Squamous cell carcinoma	2–3	Ia	T1a2N0M0	Malignant
G3	57	F	20	Striated muscle	Embryonal rhabdomyosarcom of left leg	–	Ia	T1aN0M0	Malignant
G4	58	F	70	Rectum	Malignant melanoma of rectum	–	II	T4N0M0	Malignant
G5	59	F	64	Skin	Basal cell carcinoma of head	–	II	T2N0M0	Malignant
G6	60	M	46	Skin	Squamous cell carcinoma of left chest wall	2	II	T3N0M0	Malignant
G7	61	M	59	Soft tissue	Neurofibroma of left waist	–	–	–	Benign
G8	62	F	3	Retroperitoneum	Ganglioneuroblastoma	–	–	–	Malignant
G9	63	M	48	Abdominal cavity	Malignant mesothelioma	–	–	–	Malignant
H1	64	F	48	Lymph node	Diffuse large B-cell lymphoma of right oxter	–	–	–	Malignant
H2	65	F	50	Lymph node	Diffuse B cell lymphoma of right thigh	–	–	–	Malignant
H3	66	M	53	Lymph node	Hodgkin's lymphoma over right clavicle	–	–	–	Malignant
H4	67	F	68	Lymph node	Diffuse malignant lymphoma of mandible	–	–	–	Malignant
H5	68	F	72	Bladder	Transitional cell carcinoma	3	II	T2N0M0	Malignant
H6	69	M	62	Bladder	Leiomyosarcoma	–	IIb	T2N0M0	Malignant
H7	70	F	7	Bone	Osteosarcoma of right femur inferior extremity	–	IIIb	T2N0M0	Malignant
H8	71	F	48	Retroperitoneum	Spindle cell rhabdomyosarcoma of retroperitoneum	–	IIb	T2N0M0	Malignant
H9	72	F	60	Smooth muscle	Intermediate grade malignant leiomyosarcoma of left buttock	–	IIIb	T2bN0M0	Malignant
–	–	M	58	Skin	Malignant melanoma (tissue marker)	–			Malignant

† For precise diagnosis, refer to pathology description.

**The grade 1-3 (or I-III) in Pathology Diagnosis is equivalent to well-differentiated, moderately-differentiated or poorly differentiated, respectively, under microscope.
Grade 1 or well-differentiated: Cells appear normal and are not growing rapidly.
Grade 2 or moderately-differentiated: Cells appear slightly different than normal.
Grade 3 or poorly differentiated: Cells appear abnormal and tend to grow and spread more aggressively.
Grade 4 or undifferentiated: *(for certain tumors), features are not significantly distinguishing to make it look any different from undifferentiated cancers which occur in other organs.

TNM grading:

T - Primary tumor
Tx - Primary tumor cannot be assessed
T0 - No evidence of primary tumor
Tis - Carcinoma in situ; intraepithelial or invasion of lamina propria
T1 - Tumor invades submucosa
T2 - Tumor invades muscularis propria
T3 - Tumor invades through muscularis propria into subserosa or into non-peritonealized pericolic or perirectal tissues.
T4 - Tumor directly invades other organs or structures and/or perforate visceral peritoneum

N - Regional lymph nodes
Nx - Regional lymph nodes cannot be assessed
N0 - No regional lymph node metastasis
N1 - Metastasis in 1 to 3 regional lymph nodes
N2 - Metastasis in 4 or more regional lymph nodes

M - Distant metastasis
Mx - Distant metastasis cannot be assessed
M0 - No distant metastasis
M1 - Distant metastasis